In humans, circulating FGF21 levels are elevated in metabolic syndrome, obesity, CVDs, diabetes, non-alcoholic fatty liver disease, mitochondrial myopathies, and cold exposure [26, 38, 62–69]. The gene discussed is FGF21; the disease is obesity disorder.